Issue

Case Presentation
Mr. P* is a 71-year-old widowed male resident of an assisted living facility who was recently diagnosed with Parkinson’s disease (PD), depression, and generalized anxiety. Mr. P had no prior history of mental illness. He acknowledged some regular alcohol use as a young man, consisting of drinking three to four alcoholic beverages per day over many years, but denied any alcohol-related blackouts, seizures, or treatment. Recent symptoms of anxiety and depression were attributed to a prolonged grief reaction from the loss of his wife ju

Learning Objectives
Upon completion of this educational activity, participants should be able to:
1. Discuss the most commonly ingested water-soluble vitamins, essential fatty acids, and herbs available in the United States.
2. Identify the dietary sources of water-soluble vitamins and essential fatty acids.
3. Describe the nutritional importance of the most commonly used supplements.
4. Explain the main hazardous side effects of the most commonly used over-the-counter supplements.

Release Date: April 15, 2008
Expiration Date: April 15, 2009
TARGET AUDIENCE
Internists, family practitioners, geriatricians, cardiologists, and others who care for older patients.
MEDIUM USED & METHOD OF PARTICIPATION
Read the article, complete the evaluation and post-test, and return both to: NACCME via fax at (610) 560-0502. You will receive your certificate in 6-8 weeks. If you would like to print your certif

Think of the world of accessing medications as a big bull’s eye. In Medicare’s perception, that is exactly the way that the market for pharmaceuticals should be viewed. Medicare believes it must play a very active role, as it believes that many key players will aim poorly, completely missing their desired target. And in the worst-case scenarios, prescribers’ aim will be so poor that they may actually wind up hitting patients who have adverse events because of access to an inappropriately prescribed medication. Rofecoxib is an example of “poor shooting” be

We hear a lot about the need to provide “full disclosure” to our patients—and rightfully so—but what exactly is appropriate? Just listen to the ads on television for various medications; one is struck by the litany of possible side effects that would make anyone fear taking the medication if they gave it any thought. Is this the right forum in the first place to let the public know about a medication for a specific problem? Some would argue that it is not. 
What exactly is full disclosure, and when is it okay to hold back

The trend toward self-care and patient-focused healthcare continues unabated. To have patients engaged in the management of their own care requires informed patients. The American Geriatrics Society (AGS) Foundation for Health in Aging (FHA) is committed to initiatives in public education so that older adults can act as their own advocates for quality healthcare, and to increase the awareness of the larger public about health issues in the aging population.
Resources are available to older adults, their families, and their caregiv

The International Society for the Study of the Aging Male (ISSAM) defines andropause as “a clinical and biochemical syndrome associated with advancing age and characterized by a deficiency in serum androgen levels with or without a decrease in geriatric sensitivity to androgens.”1 It has also been described as “a man over fifty years of age who has a cluster of symptoms and a low testosterone level.”2-4
History of Male Menopause
Testosterone deficiency was originally conceptualized in the Ta